BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29360983)

  • 1. Modification of histone by glyoxal: recognition of glycated histone containing advanced glycation adducts by serum antibodies of type 1 diabetes patients.
    Ansari NA; Chaudhary DK; Dash D
    Glycobiology; 2018 Apr; 28(4):207-213. PubMed ID: 29360983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
    Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
    Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
    Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
    Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected crosslinking and diglycation as advanced glycation end-products from glyoxal.
    Lopez-Clavijo AF; Duque-Daza CA; Soulby A; Canelon IR; Barrow M; O'Connor PB
    J Am Soc Mass Spectrom; 2014 Dec; 25(12):2125-33. PubMed ID: 25315462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation.
    Ruggiero-Lopez D; Lecomte M; Moinet G; Patereau G; Lagarde M; Wiernsperger N
    Biochem Pharmacol; 1999 Dec; 58(11):1765-73. PubMed ID: 10571251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific chemoproteomic profiling of targets of glyoxal.
    Chen Y; Qin W; Li Z; Guo Z; Liu Y; Lan T; Wang C
    Future Med Chem; 2019 Dec; 11(23):2979-2987. PubMed ID: 31663776
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Glyoxal Modification on a Critical Arginine Residue (Arg-31α) of Hemoglobin: Physiological Implications of Advanced Glycated end Product an
    Banerjee S
    Protein Pept Lett; 2020; 27(8):770-781. PubMed ID: 31774041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycation of H1 Histone by 3-Deoxyglucosone: Effects on Protein Structure and Generation of Different Advanced Glycation End Products.
    Ashraf JM; Rabbani G; Ahmad S; Hasan Q; Khan RH; Alam K; Choi I
    PLoS One; 2015; 10(6):e0130630. PubMed ID: 26121680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Repair from Glycation by Glyoxals by the DJ-1 Family Maillard Deglycases.
    Mihoub M; Abdallah J; Richarme G
    Adv Exp Med Biol; 2017; 1037():133-147. PubMed ID: 29147907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of an unusual advanced glycation end-product (AGE) derived from glyoxal using mass spectrometry.
    Lopez-Clavijo AF; Duque-Daza CA; Romero Canelon I; Barrow MP; Kilgour D; Rabbani N; Thornalley PJ; O'Connor PB
    J Am Soc Mass Spectrom; 2014 Apr; 25(4):673-83. PubMed ID: 24470193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glycation derived from α-dicarbonyl compounds on the in vitro digestibility of β-casein and β-lactoglobulin: A model study with glyoxal, methylglyoxal and butanedione.
    Zhao D; Le TT; Larsen LB; Li L; Qin D; Su G; Li B
    Food Res Int; 2017 Dec; 102():313-322. PubMed ID: 29195953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo detection of histone H1 modified with advanced glycation end products.
    Pashikanti S; Boissonneault GA; Cervantes-Laurean D
    Free Radic Biol Med; 2011 May; 50(10):1410-6. PubMed ID: 21315148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe³⁺: its potential role in prompt recognition of diabetes mellitus auto-antibodies.
    Shahab U; Tabrez S; Khan MS; Akhter F; Khan MS; Saeed M; Ahmad K; Srivastava AK; Ahmad S
    Chem Biol Interact; 2014 Aug; 219():229-40. PubMed ID: 24968179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.
    Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW
    Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem mass spectrometry for the study of glyoxal-derived advanced glycation end-products (AGEs) in peptides.
    Lopez-Clavijo AF; Duque-Daza CA; O'Connor PB
    Rapid Commun Mass Spectrom; 2014 Jan; 28(1):25-32. PubMed ID: 24285387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process.
    Ansari NA; Moinuddin ; Alam K; Ali A
    Hum Immunol; 2009 Jun; 70(6):417-24. PubMed ID: 19332092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of Pentosidine Cross-Linking in Myoglobin by Glyoxal: Detection of Fluorescent Advanced Glycation End Product.
    Banerjee S
    J Fluoresc; 2017 Jul; 27(4):1213-1219. PubMed ID: 28299531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glyoxal-induced modification enhances stability of hemoglobin and lowers iron-mediated oxidation reactions of the heme protein: An in vitro study.
    Banerjee S
    Int J Biol Macromol; 2018 Feb; 107(Pt A):494-501. PubMed ID: 28888546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of binding by sulfonylureas with glyoxal- and methylglyoxal-modified albumin by immunoextraction using affinity microcolumns.
    Rodriguez EL; Tao P; Woolfork AG; Li Z; Matsuda R; Sun Z; Hage DS
    J Chromatogr A; 2021 Feb; 1638():461683. PubMed ID: 33223150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus.
    Raghav A; Ahmad J; Alam K
    PLoS One; 2017; 12(5):e0176970. PubMed ID: 28520799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.